Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05804942 Recruiting - Healthy Clinical Trials

Metabolic Response to Variations in Dietary Glycemic Index

Start date: April 13, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to compare metabolic response to variations in dietary glycemic index in healthy participants. The main questions it aims to answer are: • What are the metabolic hunger and food intake responses to different levels of glycemic index on the background of otherwise constant macronutrient composition? Participants will come to the lab after an overnight fast and body composition will be tested by bio-impedance analysis and magnetic resonance imaging. They will then be randomized to eat one of three standardized breakfasts varying in the glycemic index. Circulating glucose levels will be monitored using a continuous glucose monitor and blood samples will be collected to measure metabolic and hormone factors in the serum. Participants will also rate their hunger at 0, 30, 60, 120, 180, 240 and 300 minutes. After 5 hours they will eat a free choice meal from a standardized selection buffet (test meal).

NCT ID: NCT05804721 Completed - Healthy Clinical Trials

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Start date: October 10, 2022
Phase: Phase 1
Study type: Interventional

Comparative randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Aripiprazole from Apipe 10 mg orally disintegrating tablets (Man. by: P&C Labs (Pellets&CR Products), Egypt) versus Abilify 10 mg orodispersible tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands ) in Healthy Human Volunteers Under Fasting Condition

NCT ID: NCT05804513 Recruiting - Healthy Clinical Trials

The Effect of Lixisenatide on the Effect of Pituitary Hormones

Start date: April 17, 2023
Phase: Phase 4
Study type: Interventional

The current study has two aims: 1. to test the hypothesis that a single dose of lixisenatide can be used as a growth hormone stimulation test; 2. to test if the growth hormone-stimulating effect is mediated by changes in blood glucose. The secondary objective of the study is to monitor the effect of lixisenatide on other pituitary hormones and physiological parameters (blood glucose, blood pressure, heart rate, nausea).

NCT ID: NCT05804344 Recruiting - Healthy Clinical Trials

Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning

Start date: October 25, 2022
Phase: N/A
Study type: Interventional

Groups of unimpaired participants will all receive speech motor training of nonwords, and six tDCS conditions will be compared: anodal tDCS over speech motor regions; cathodal tDCS over speech motor regions; anodal tDCS over left frontal regions; cathodal tDCS over left frontal regions; cathodal stimulation over non-speech motor regions (anodal already collected);and sham tDCS (no stimulation). This will address a basic science question about whether the mechanism underlying speech motor learning requires premotor and motor cortical regions to be stimulated, which has implications for treatment of acquired speech impairment. The primary outcome measure will be the difference in production accuracy and changes in motor acuity (measured with duration) of novel consonant cluster production.

NCT ID: NCT05804279 Completed - Healthy Clinical Trials

Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults

Start date: December 28, 2022
Phase: Phase 1
Study type: Interventional

Pharmacokinetics and safety of BPDO-1603 or BPDO-16031 and BPDO-16033 administration in healthy adults. Randomized, open-label, single-dose, cross-over, Phase 1 study

NCT ID: NCT05802875 Recruiting - Healthy Clinical Trials

Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This clinical trial is to test the efficacy of a Resilience Training (RASMUS) compared to an active control condition (Progressive Muscle Relaxation, PMR) on resilience, psychological distress, and other clinical variables in a group of people out of the general population with clinically relevant psychological symptoms in the context of the COVID-19 pandemic. In addition, this randomized, controlled, parallel-group study will test the efficacy of RASMUS and PMR in relation to brain structure, function, and metabolite levels. In summary, the main study examines the efficacy of two potentially helpful interventions to improve mental health, whereas the imaging sub-study investigates the potential effects of these interventions on brain volumetry and cortical thickness, on metabolite levels in stress-related brain regions, on brain responses, as well as on functional brain connectivity and communication.

NCT ID: NCT05802472 Withdrawn - Healthy Clinical Trials

Effect of an Polyphenolic Beverage in Healthy Volunteers

PB
Start date: April 6, 2022
Phase: N/A
Study type: Interventional

Currently, there are different strategies to prevent the effect of beverages and foods on blood glucose levels after ingestion. In this sense, polyphenols are a promising field; these compounds are secondary metabolites produced by plants, vegetables, and fruits; of these compounds, gallic acid, quercetin, and kaempferol stand out for their antihyperglycemic characteristics through a) complex formation, b) enzymatic inhibition, c) affecting transport and, d) stimulation of the secretion of intestinal satiety hormones. Vachellia farnesiana (VF) is a shrub distributed in arid, semi-arid, and tropical regions of Mexico and the world. The polyphenols of the fruits of VF in pre-clinical studies by this research group have shown important antioxidant activity and antihyperglycemic effects. The present proposal aims to evaluate the effect of the polyphenolic extract of Vachellia farnesiana on glycemic response and to monitor liver and renal function tests as a safety control in healthy volunteers through developing a Phase I clinical study.

NCT ID: NCT05801653 Completed - Healthy Clinical Trials

Health Effects of Oat Bioactives (Betaglucan) in Human

Start date: March 8, 2023
Phase: N/A
Study type: Interventional

Aim of the study is to investigate health effects of oats and oat derived components, in human intervention studies, with the purpose to build new knowledge for development of cardiometabolic protective foods.

NCT ID: NCT05800730 Completed - Healthy Clinical Trials

Westlake Precision Nutrition Study 2 (WePrecision2)

WePrecision2
Start date: May 8, 2023
Phase: N/A
Study type: Interventional

This is a dietary intervention study, which aims to explore different diet challenges for glucose metabolism, including carbohydrates and fasting dietary pattern. Considering the glucose responses to the same food are largely heterogeneous among people, this study integrates the concepts of precision nutrition and N-of-1 design. The study also aims to discover the different impact of the time-restricted diet (TRD) and the energy-restricted diet (ERD) on host metabolic health and our hair growth.

NCT ID: NCT05800314 Not yet recruiting - Healthy Clinical Trials

Effectiveness of Different Scoring Systems

Start date: November 2023
Phase:
Study type: Observational

1. Assessment of the effectiveness of a validated poisoning specific scoring system (new poisoning mortality [PMS]) and other commonly used scoring systems for all acutely ill patient (Simple clinical score [SCS] and Rapid Emergency Medicine Score [REMS]) at Assiut university hospitals. 2. Comparison between these scoring systems in terms of sensitivity and specificity in both children and adults. 3. Design a toxicological sheet for Assiut poison control center that include this poisoning scoring system so it could help in assessing prognosis of acute poisoned cas